IMV ServiceTrak ranked GE Healthcare No. 1 for CT and MR Service in a comparison against five other manufacturers of the modalities.

An independent marketing research firm specializing in medical imaging, IMV conducts its assessment annually and focuses on service response, service quality and remote diagnostics.


Two of the six astronauts from the shuttle mission Atlantis became part of an ongoing cardiovascular study at NASA about four hours after the shuttle landed at the Johnson Space Center early last Friday morning. Imaging their hearts — both pre- and post-flight — with Philips’ iE33, 3-D echocardiography system, investigators for the ongoing research were given just 30 minutes to collect data that will eventually help them determine why loss of heart mass occurs after space flight, and further, how inactivity impacts heart health.

Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent System were presented at the World Congress of Cardiology conference in Barcelona, Spain. XIENCE V, which has received CE Mark approval, is currently an investigational device in the U.S. and Japan — Abbott says it plans to initiate European launch of the coronary DES in October.

Japanese radiologist Katsumi Nakamura, M.D., of Tobata Kyoritsu Hospital, received first place honors for his research in the area of non-contrast magnetic resonance angiography (MRA) imaging at the 14th annual International Society for Magnetic Resonance in Medicine (ISMRM) Scientific Meeting & Exhibition.

Siemens completed its acquisition of Diagnostic Products Corp. (DPC) in late July, marking a significant milestone for Siemens as it enters the in-vitro diagnostics (IVD) market. Together with DPC, Siemens Medical Solutions says it will become the first full service diagnostics company.

Enrollment is complete for a landmark study designed to increase clinical understanding of vulnerable plaque, the deadly, lipid-rich coronary plaque that ruptures without warning or symptoms and possibly the source of most heart attacks.

New SPECT/CT, cardiovascular IT and PET/CT technologies were on display by Philips Medical Systems at the American Society of Nuclear Cardiology (ASNC) annual meeting in Montreal.

Thousands of lives potentially saved and hospital costs reduced are the predicted outcomes if more hospitals adopt certain quality measures on a wider scale, according to an analysis by Premier Inc. healthcare alliance, headquartered in San Diego, which is owned by more than 200 of the nation's leading not-for-profit hospitals and healthcare systems.

The FDA has approved Medtronic’s Adapta portfolio of fully automatic pacemakers. The system provides physiologic pacing customized to the needs of individual patients, helping to set new standards of personalized care, the company stated.

GE Healthcare and Volcano Corp. have announced FDA 510(k) clearance for the integration of Volcano’s intravascular ultrasound imaging (IVUS) capabilities onto the best-of-class Innova all-digital X-ray cath lab imaging system

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now